Business Description
Qyuns Therapeutics Co Ltd
ISIN : CNE1000069W9
Share Class Description:
HKSE:02509: Ordinary Shares - Class HDescription
Qyuns Therapeutics Co Ltd is a a clinical-stage biotech company focused on biologic therapies for autoimmune and allergic diseases, with a self-developed drug pipeline.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.09 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 1.17 | |||||
| Debt-to-EBITDA | -2.81 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.29 | |||||
| 9-Day RSI | 63.94 | |||||
| 14-Day RSI | 59.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.66 | |||||
| Quick Ratio | 1.65 | |||||
| Cash Ratio | 1.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -29.97 | |||||
| ROA % | -14.99 | |||||
| ROIC % | -27.4 | |||||
| ROC (Joel Greenblatt) % | -37.09 | |||||
| ROCE % | -18.52 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 19.07 | |||||
| Price-to-Tangible-Book | 20.63 | |||||
| EV-to-EBIT | -43.49 | |||||
| EV-to-EBITDA | -46.39 | |||||
| EV-to-FCF | -75.57 | |||||
| Earnings Yield (Greenblatt) % | -2.3 | |||||
| FCF Yield % | -1.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Qyuns Therapeutics Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | |||
| EPS (TTM) (HK$) | -0.659 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 59.51 | ||
| 14-Day ATR (HK$) | 1.711211 | ||
| 20-Day SMA (HK$) | 26.205 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (HK$) | 18.14 - 30.55 | ||
| Shares Outstanding (Mil) | 222.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Qyuns Therapeutics Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Qyuns Therapeutics Co Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Qyuns Therapeutics Co Ltd Frequently Asked Questions
What is Qyuns Therapeutics Co Ltd(HKSE:02509)'s stock price today?
The current price of HKSE:02509 is HK$27.65. The 52 week high of HKSE:02509 is HK$30.55 and 52 week low is HK$18.14.
When is next earnings date of Qyuns Therapeutics Co Ltd(HKSE:02509)?
The next earnings date of Qyuns Therapeutics Co Ltd(HKSE:02509) is .
Does Qyuns Therapeutics Co Ltd(HKSE:02509) pay dividends? If so, how much?
Qyuns Therapeutics Co Ltd(HKSE:02509) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers